Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' original application for deferasirox, a generic iron chelator for chronic iron overload due to blood transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)